Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapy.
about
Cytochrome P450 3A1 mediates 2,2',4,4'-tetrabromodiphenyl ether-induced reduction of spermatogenesis in adult ratsIrradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivoInhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer7-Ketocholesterol induces P-glycoprotein through PI3K/mTOR signaling in hepatoma cellsThe anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy.IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification.Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas.Defining the Akt1 interactome and its role in regulating the cell cycle.
P2860
Q27314776-FFDFD9A9-25E8-4579-87B6-69F137D76632Q28485143-4DE0FA3B-2EE7-444D-8025-74B69F536CF2Q28535406-7FD3CE82-380E-4274-9B9F-80FEADB9E089Q34185571-898EB268-4624-430F-A1CF-DBAC86AC1793Q35856555-93B615BD-AEFC-4E53-888A-3E61C742A1E1Q36144821-1F682573-91FC-4594-B11F-0DEE1E1CA328Q36535127-AFEFF0DC-20DE-4547-97C7-D8C4F16B110BQ37688519-14889FCD-44FD-4B1F-86EF-7423ECCE0D6BQ38175044-FC3AB071-1B82-4D12-82A0-03A5A2D80033Q38903238-B5F4798C-569F-46EF-99BF-9FB41AAD53B3Q38986202-0C7CC9D6-3214-4019-AA56-E0FFC36FDD0CQ41270773-294D20B2-5C26-4290-A484-142B585323C3Q49230519-52780138-64B1-486A-9666-B23B38B5F9B0
P2860
Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Therapeutic implications of ta ...... ng module in melanoma therapy.
@ast
Therapeutic implications of ta ...... ng module in melanoma therapy.
@en
type
label
Therapeutic implications of ta ...... ng module in melanoma therapy.
@ast
Therapeutic implications of ta ...... ng module in melanoma therapy.
@en
prefLabel
Therapeutic implications of ta ...... ng module in melanoma therapy.
@ast
Therapeutic implications of ta ...... ng module in melanoma therapy.
@en
P2093
P2860
P1476
Therapeutic implications of ta ...... ng module in melanoma therapy.
@en
P2093
Ali R Jazirehi
Mohsen Damavand
Peter B Wenn
P2860
P304
P577
2012-02-15T00:00:00Z